secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cartesian Therapeutics, Inc. (RNAC)
CIK:        0001453687
Form:       8-K
Filed at:   2024-01-19T23:59:59+00:00
Accession:  0001453687-24-000030
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Cartesian Therapeutics receives Nasdaq notice of non-compliance with minimum bid price requirement
--------------------------------------------------------------------------------

- Nasdaq notified Cartesian on Jan 17, 2024 that its common stock closing bid price fell below $1.00 for 30 consecutive business days.
- Company has until July 15, 2024 to regain compliance; must close at or above $1.00 for 10 consecutive business days.
- If not compliant by July 15, may qualify for additional 180-day period by transferring to Nasdaq Capital Market and meeting other standards.
- Cartesian intends to monitor bid price and consider available options; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453687/000145368724000030/0001453687-24-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453687/000145368724000030/rnac-20240117.htm
  HTML page:      https://secwatch.observer/filing/0001453687-24-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer